| Identification | Back Directory | [Name]
Cyclobutanecarboxylic acid, 3-[2-[4-(8-chloro-2-quinolinyl)phenoxy]ethoxy]-, cis- | [CAS]
2355225-38-4 | [Synonyms]
HBV-IN-16
Cyclobutanecarboxylic acid, 3-[2-[4-(8-chloro-2-quinolinyl)phenoxy]ethoxy]-, cis- | [Molecular Formula]
C22H20ClNO4 | [MOL File]
2355225-38-4.mol | [Molecular Weight]
397.85 |
| Hazard Information | Back Directory | [Uses]
HBV-IN-16 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-16 is a quinoline derivative. HBV-IN-16 has the potential for the research of HBV infection (extracted from patent WO2019121357A1, compound 1)[1]. | [References]
[1] Song Feng, et al. Novel quinoline compounds for the treatment and prophylaxis of hepatitis b virus disease. Patent WO2019121357A1. |
|
|